Literature DB >> 3877932

Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.

D J Dowbenko, J R Bell, C V Benton, J E Groopman, H Nguyen, D Vetterlein, D J Capon, L A Lasky.   

Abstract

A retrovirus [lymphoadenopathy-associated virus, human T-cell leukemia virus type III, acquired immunodeficiency syndrome (AIDS)-related virus] suspected of causing AIDS has been isolated recently. The detection of exposure to this retrovirus in donors of various blood products is important to prevent transmission of the disease from these donors to recipients. In the majority of cases, the detection of antibodies directed against either the viral core protein, a Mr approximately equal to 24,000 protein termed p24 gag, or the viral envelope antigen is proof of previous viral infection. Thus, we have expressed the p24 gag antigen in Escherichia coli in order to produce a diagnostic reagent for the detection of virus exposure. The bacterially synthesized antigen reacts with human and rabbit antisera directed against the native p24 gag protein in both electrophoretic transfer blot assay and ELISA. In addition, the use of bacterially produced antigens for ELISAs gave results that were comparable to those obtained by using antigens isolated from the virus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877932      PMCID: PMC391411          DOI: 10.1073/pnas.82.22.7748

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The binding of an avian myeloblastosis virus basic 12,000 dalton protein to nucleic acids.

Authors:  B J Smith; J M Bailey
Journal:  Nucleic Acids Res       Date:  1979-12-11       Impact factor: 16.971

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.

Authors:  D P Bolognesi; R Luftig; J H Shaper
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

6.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

8.  Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins.

Authors:  S Oroszlan; T D Copeland; L E Henderson; J R Stephenson; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Human T-cell leukemia virus type II: primary structure analysis of the major internal protein, p24 and the nucleic acid binding protein, p15.

Authors:  S G Devare; Y Kim; J L Fox; J Getchell; C Cabradilla; V S Kalyanaraman
Journal:  Virology       Date:  1985-04-15       Impact factor: 3.616

View more
  8 in total

1.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 3.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

4.  Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector.

Authors:  S I Hu; S G Kosowski; K F Schaaf
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

5.  [Serologic AIDS diagnosis with polypeptides obtained by genetic technics of the human immunodeficiency virus (HIV-1)].

Authors:  A Lenz; J von Hintzenstern; O Erlwein; S Ellinger; M Bröker; B Fleckenstein; G Jahn
Journal:  Klin Wochenschr       Date:  1987-11-02

6.  Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.

Authors:  T D Ly; L Martin; D Daghfal; A Sandridge; D West; R Bristow; L Chalouas; X Qiu; S C Lou; J C Hunt; G Schochetman; S G Devare
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.

Authors:  J W Eichberg; J M Zarling; H J Alter; J A Levy; P W Berman; T Gregory; L A Lasky; J McClure; K E Cobb; P A Moran
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay.

Authors:  Peihu Fan; Xiaojun Li; Weiheng Su; Wei Kong; Xianggui Kong; Zhenxin Wang; Youchun Wang; Chunlai Jiang; Feng Gao
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.